Replies to post #138289 on Biotech Values

[TastyTheElf]

Does anyone actually know what the efficacy halt endpoints were for the 2IA, instead of blatant speculation (which all started the blow-away numbers to begin with, with the stat analysis).

Why is it a big secret

My point exactly. If it were really "standard" OBF, we have the trial powering, any schmuck can simply calculate the p-values and estimate the HRs.